Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$25.61 - $35.1 $2,125 - $2,913
-83 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$33.54 - $40.55 $6,137 - $7,420
-183 Reduced 68.8%
83 $3,000
Q2 2021

Aug 11, 2021

BUY
$34.54 - $47.25 $7,011 - $9,591
203 Added 322.22%
266 $11,000
Q4 2020

Feb 12, 2021

SELL
$45.3 - $60.27 $1,223 - $1,627
-27 Reduced 30.0%
63 $4,000
Q3 2020

Nov 13, 2020

BUY
$47.45 - $62.95 $2,087 - $2,769
44 Added 95.65%
90 $4,000
Q2 2020

Aug 13, 2020

BUY
$46.85 - $61.05 $2,155 - $2,808
46 New
46 $3,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.